Quick Answer
LIFECORE BIOMEDICAL, INC. \DE\ reported Total Assets of $239.34 million for the year ending 2025.
- LIFECORE BIOMEDICAL, INC. \DE\ showed a decrease of -5.8% in Total Assets from 2024 to 2025.
- This data is from LIFECORE BIOMEDICAL, INC. \DE\'s annual report (Form 10-K), filed with the SEC on August 7, 2025.
- XBRL data for this metric is available from 2011 to 2025 (24 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2011: $208.89 million | Q4 2011: $209.41 million | Q1 2012: $211.55 million | Q3 2012: $267.96 million | Q4 2012: $278.11 million | Q1 2013: $283.00 million | Q3 2013: $290.83 million | Q4 2013: $302.26 million | Q1 2014: $306.78 million | Q3 2014: $325.94 million | Q4 2014: $341.10 million | Q1 2015: $340.30 million | Q3 2015: $342.59 million | Q4 2015: $361.11 million | Q1 2016: $328.68 million | Q3 2016: $343.77 million | Q4 2016: $341.34 million | Q1 2017: $346.14 million | Q3 2017: $366.97 million | Q4 2017: $379.31 million | Q1 2018: $385.84 million | Q3 2018: $402.90 million | Q4 2018: $411.65 million | Q1 2019: $501.58 million | Q3 2019: $546.14 million | Q4 2019: $560.00 million | Q1 2020: $550.06 million | Q3 2023: $245.62 million | Q4 2023: $245.82 million | Q1 2024: $246.24 million | Q3 2024: $246.82 million | Q4 2024: $255.39 million | Q1 2025: $237.69 million | Q2 2025: $239.34 million | Q3 2025: $235.20 million.
- Over the full 24 years of available data (2011 to 2025), LIFECORE BIOMEDICAL, INC. \DE\'s Total Assets has grown by 16.0%.
- Historical annual values: Fiscal year 2025: $239.34 million | Fiscal year 2024: $253.96 million | Fiscal year 2023: $253.55 million | Fiscal year 2023: $236.66 million | Fiscal year 2022: $275.97 million | Fiscal year 2022: $266.38 million | Fiscal year 2022: $274.70 million | Fiscal year 2022: $324.24 million | Fiscal year 2021: $421.31 million | Fiscal year 2021: $444.73 million | Fiscal year 2021: $501.89 million | Fiscal year 2021: $506.86 million | Fiscal year 2020: $498.07 million | Fiscal year 2020: $503.04 million | Fiscal year 2020: $293.50 million | Fiscal year 2019: $519.09 million | Fiscal year 2018: $404.70 million | Fiscal year 2017: $358.61 million | Fiscal year 2016: $342.65 million | Fiscal year 2015: $346.47 million | Fiscal year 2014: $313.62 million | Fiscal year 2013: $290.94 million | Fiscal year 2012: $277.69 million | Fiscal year 2011: $206.31 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: